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Atorvastatin provides a new 
lipidome improving early 
regeneration after partial 
hepatectomy in osteopontin 
deficient mice
Maitane Nuñez-Garcia1, Beatriz Gomez-Santos1, Diego Saenz de Urturi1, Daniela Mestre1,2, 
Francisco Gonzalez-Romero1, Xabier Buque1,2, Virginia Gutiérrez-de Juan3, 
María Luz Martinez-Chantar3, Wing-Kin Syn4,5, Olatz Fresnedo1 & Patricia Aspichueta1,2
Osteopontin (OPN), a multifunctional cytokine that controls liver glycerolipid metabolism, is involved 
in activation and proliferation of several liver cell types during regeneration, a condition of high 
metabolic demands. Here we investigated the role of OPN in modulating the liver lipidome during 
regeneration after partial-hepatectomy (PH) and the impact that atorvastatin treatment has over 
regeneration in OPN knockout (KO) mice. The results showed that OPN deficiency leads to remodeling 
of phosphatidylcholine and triacylglycerol (TG) species primarily during the first 24 h after PH, with 
minimal effects on regeneration. Changes in the quiescent liver lipidome in OPN-KO mice included TG 
enrichment with linoleic acid and were associated with higher lysosome TG-hydrolase activity that 
maintained 24 h after PH but increased in WT mice. OPN-KO mice showed increased beta-oxidation 
24 h after PH with less body weight loss. In OPN-KO mice, atorvastatin treatment induced changes in 
the lipidome 24 h after PH and improved liver regeneration while no effect was observed 48 h post-PH. 
These results suggest that increased dietary-lipid uptake in OPN-KO mice provides the metabolic 
precursors required for regeneration 24 h and 48 h after PH. However, atorvastatin treatment offers a 
new metabolic program that improves early regeneration when OPN is deficient.
The liver has the capacity for regeneration after cellular damage or surgery resection. During regeneration, liver 
cells need to acquire sufficient energy and metabolic precursors to support the metabolic demands for rapid pro-
liferation. Thus, a variety of metabolic pathways is switched on1. The synthesis of phosphatidylcholine (PC), the 
mayor phospholipid in cellular membranes, is coordinated with the activation of the cell cycle2 and is an essential 
step in cell proliferation3,4. However, the lack of CTP: phosphocholine cytidyltransferase in mice, the rate limiting 
enzyme responsible for producing nearly 70% of liver PC5, does not inhibit liver regeneration after partial hepa-
tectomy (PH)6. Catabolism of PC generate compounds required for triacylglycerol (TG) synthesis7, which are 
major constituents of lipid droplets and accumulate transiently in hepatocytes after PH. It has been proposed that 
the hypoglycemia that follows PH induces systemic lipolysis providing the required fatty acids (FA) for hepatic 
lipogenesis8. This process will lead to rapid storage of intracellular TG within the regenerating liver, thus inducing 
a transient regeneration-associated steatosis9.
Although multiple studies have analyzed the expression patterns and functions of cytokines immediately after 
PH, the specific roles of each of these factors in the regulation of liver metabolic fluxes during regeneration 
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remains poorly understood1,10,11. Osteopontin (OPN) is a multifunctional cytokine that is expressed in vari-
ous tissues12,13. It plays an important role in obesity12,14 and in fibrogenesis during non-alcoholic steatohepatitis 
(NASH) progression15. It also modulates the activation and proliferation of several cell types during regenera-
tion16. Recently, we reported that OPN controls de novo FA synthesis in hepatocytes and that liver PC concen-
tration is regulated by circulating OPN17. In fact, high levels of OPN increase liver PC concentration, while PC 
concentration is low in OPN deficient mice17. We also found that inhibiting de novo cholesterogenesis, which is 
increased in OPN-KO mice liver, results in the restoration of PC concentration in OPN-KO mice, exemplifying 
the cross-talk between these metabolic pathways17. In this study, we investigated the roles of OPN in modulating 
liver TG and PC concentrations during liver regeneration after PH and the effects of atorvastatin on the regener-
ative liver lipidome in OPN deficient mice. The current study showed that serum OPN levels are increased 24 h 
after PH in WT mice, and that OPN deficiency led to alterations in the remodeling of PC and TG species during 
the first 24 h after PH. OPN deficiency had minimal effects on liver regeneration. We found that changes in 
quiescent liver lipidome in OPN-KO mice were associated with higher lysosome TG hydrolytic activity that was 
maintained 24 h after PH (but increased in WT mice). In sum, despite changes in PC concentration and PC and 
TG composition with OPN deficiency, remodeling of the liver lipid metabolism provides the metabolic precur-
sors necessary for liver regeneration after PH. Treatment with atorvastatin ushered a new metabolic program that 
increased liver PC concentrations in OPN-KO mice 24 h after PH and promoted liver regeneration in these mice.
Results
OPN modulates liver TG and PC metabolism during liver regeneration after partial hepatectomy. 
In the early phases of liver regeneration after PH, the liver undergoes robust metabolic adaptations to support 
proliferation, remodeling and differentiation, whilst maintaining essential liver functions. Several studies had 
previously reported on the importance of various cytokines in the early phases of liver regeneration (i.e. first 
few hours) after PH1. In fact, it has been described that initiation of liver regeneration is defective in OPN defi-
cient mice18. We recently reported that OPN regulates PC and cholesterol metabolism cross-talk in the quiescent 
mouse liver and that OPN deficient mice exhibit decreased de novo FA and TG synthesis in hepatocytes while 
liver TG content maintains unaltered17. Thus, we first evaluated if OPN plays a role in modulating the liver lipi-
dome during regeneration after 70% PH. The results show that serum OPN levels increase by nearly 2-fold 24 h 
after PH in WT mice and remain elevated 48 and 72 h after PH (Fig. 1A). Compared with WT mice, body weight 
loss was significantly lower in OPN-KO mice 24 and 48 hours after PH (Fig. 1B). These findings suggest that OPN 
regulates whole body metabolism during liver regeneration.
FAs are essential constituents of glycerolipids, and have different metabolic fates depending on their chain 
length and degree of saturation19. Therefore, to ascertain whether OPN deficiency could be associated with 
changes in the liver lipidome during regeneration, TG and PC species from quiescent livers and regenerating liv-
ers 24 and 48 h post-PH were analyzed (Fig. 1C). We found that 52% of the analyzed TG species were increased in 
quiescent OPN-KO mouse livers when compared with livers from WT mice (Fig. 1C; Supplemental Table 1), but 
these differences abated with liver regeneration (Fig. 1C; Supplemental Table 1). Changes in PC species similarly 
occurred after PH in OPN-KO mice. Specifically, 35% of the analyzed PC species were decreased in quiescent 
OPN-KO mice but differences between OPN-KO and WT mice minimized 24 h after PH, (Fig. 1C; Supplemental 
Table 1) and were maintained 48 h post -PH (Fig. 1C; Supplemental Table 1). In OPN-KO mice, the fluctuations 
in several TG species along regeneration (Fig. 1C; Supplemental Table 1), which show enrichment is some TG 
species but not in others, were not associated with changes in concentration of liver TG (Fig. 1D) or accumulation 
of lipid droplets (Fig. 1D), while those of PC species were linked to decrease PC concentration in quiescent and 
regenerative liver (Fig. 1D). PCs can be catabolized to fatty acids and diglycerides through the action of different 
phospholipases being a source of TGs7,20. Here we observed that activation of phospholipase D (PLD) (Fig. 1E) 
or of calcium dependent phospholipase A2 (PLA2) (Fig. 1F) remained unaltered in the quiescent OPN-KO liver. 
Besides, the results showed that in liver of OPN deficient mice, there is no change in the LysoPC to PC ratio 
(Fig. 1E), which is an indirect indicator of PLA2 activity.
Considering that PC and TG de novo synthesis are reduced in OPN-KO mice hepatocytes while liver TG con-
centration remains unaltered17, to know the contribution of dietary FAs we next analyzed if TG and PC species 
containing the essential linoleic acid (18:2) were altered. We found that most of the TG species that were increased 
in OPN-KO livers were enriched in linoleic acid (18:2); these FAs cannot be synthesized by the cell and must be 
acquired from the diet (Fig. 2A; Supplemental Table 1). We also observed that PC species containing the linoleic 
acid (18:2) were reduced in the quiescent OPN-KO livers when compared with WT livers (Fig. 2A; Supplemental 
Table 1). In aggregate, these results suggest that the decreased de novo TG synthesis detected in OPN-KO mice 
liver is compensated by increased dietary FA uptake. This compensation however, does not occur with PC loss.
Since the big changes in liver lipid content during regeneration occur mainly 24 hours after PH, we also eval-
uated if the increased TG storage was associated with the enrichment in linoleic acid. The results showed that 
increase in linoleic acid-containing TG species was significantly more marked in WT compared with OPN-KO 
mice liver (Fig. 2B; Supplemental Table 1). Changes in linoleic-acid containing PC species however, were less 
consistent than the former (i.e. some containing the linoleic acid increased while other decreased 24 h after PH) 
(Fig. 2B; Supplemental Table 1).
Liver lipid oxidation rate is increased in OPN-KO mice 24 h post-PH. Transient liver TG accumula-
tion during PH has been correlated with changes in lipid oxidation21,22. Herein, we assessed liver lipid oxidation 
rate by measuring the rate of conversion of 14C- palmitate into acid-soluble metabolites (ASM) or CO2 (Fig. 3A). 
24 h post-PH, incomplete (ASM) and complete (CO2) lipid oxidation was increased in OPN -KO mice when 
compared to WT mice (Fig. 3A). By contrast, no differences were seen in the quiescent liver or in the regenerating 
liver 48 h post-PH.
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Figure 1. Modulation of liver lipidome after partial hepatectomy in OPN-KO mice. Osteopontin Knockout 
(OPN-KO) mice and their controls (WT) were subjected to partial hepatectomy (PH), and blood and liver were 
collected before and 24 h, 48 h and 72 h post-PH. (A) Serum OPN was quantified by ELISA in WT mice. (B) 
Animal weight, before PH and during liver regeneration (0 h, 24 h, 48 h and 72 h), is represented and the values 
are expressed as the percentage of the initial weight (100%). (C) Heat map representation of triacylglycerol 
(TG) and phosphatidylcholine (PC) metabolite subspecies abundance. In red, the increased lipids, in green the 
decreased lipids, in grays, the significant differences. (D) Representative liver sections stained with H&E (up) 
and Sudan III (down) and liver TG and phosphatidylcholine (PC) content is represented in nmol/gram of liver 
(right). (E) Phosphorylated (Thr-147) phospholipase D1 (P-PLD1) and total phospholipase D1 (PLD1) protein 
levels were assessed by immunoblotting. (F) Calcium free posphorylated (Ser-505) phospholipase A2 (P-PLA2) 
and total phopholipase A2 (PLA2) protein levels were assessed by immunoblotting.The LysoPC (LPC) to PC 
ratio was measured. In all the immunoblots glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as 
a loading control. Values are mean ± SEM from 5–8 animals per group. Significant differences are denoted by 
*p < 0.05 (Student’s t test). Differences between quiescent and 24 h or 24 h, 48 h and 72 h post-PH are indicated 
by †p < 0.05, ††p < 0.01 and †††p < 0.001 (Student’s t test).
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For mitochondrial lipid oxidation to occur, FAs need to be converted into acylcarnitine by CPT-1 before being 
transported from the cytosol. Importantly, altered acylcarnitines content has been associated with changes in lipid 
oxidation23. In this study, we observed that acylcarnitine levels were higher in livers of OPN-KO mice under basal 
(quiescent) conditions. Although acylcarnitine levels were increased in both OPN-KO and WT mice 24 after 
PH, the increase was more marked in WT mice (Fig. 3B), in which beta oxidation was not increased (Fig. 3A). 
The increase in acylcarnitine content was 4.5 fold for the WT mice while it was 2.9 fold for OPN-KO mice. 48 h 
post-PH, acylcarnitines were even higher in WT mice while decreased in the KO mice (Fig. 3B).
Next, we found that 24 h post-PH, the increased lipid oxidation was associated with increased percentage of 
cells positive for dihydroethidium (DHE) (Fig. 3C), which have been used extensively to evaluate reactive oxygen 
species (ROS) production while no differences were observed in malondialdehyde (MDA) (Fig. 3D), which is a 
natural bi-product of lipid peroxidation, or in oxidated fatty acids (FA) (Fig. 3D, Supplemental Fig. 1B).
Lysosomal TG hydrolase activity is increased in livers from OPN-KO mice while circulating TG 
and PC into lipoproteins are unchanged. Given that liver lipid beta oxidation was higher (Fig. 3A) 24 
post-PH in OPN-KO mice as compared to WT mice while there were no changes in liver TG concentration, we 
next evaluated if increased liver lipoprotein uptake could be involved in providing the energy source required. The 
results showed that basal lysosomal TG hydrolase (TGH) activity was higher in the OPN-KO liver (Fig. 4A) and 
that TGH activity increased 24 h post-PH in WT mice (Fig. 4A). In the quiescent liver, Cd36 and very-low-density 
lipoprotein receptor (Vldlr) mRNA (Fig. 4B) and protein levels (Fig. 4C) were higher in OPN-KO mice than in 
WT mice. There was also and increase in low-density lipoprotein receptor (Ldlr) mRNA levels. After PH, Cd36 
mRNA remained significantly higher in OPN-KO livers compared with WT livers (Fig. 4B) while no statistically 
Figure 2. Liver triacylglycerol is enriched in the dietary linoleic acid (18:2) in OPN-KO mice. Osteopontin 
knockout (OPN-KO) mice and their controls (WT) were subjected to partial hepatectomy (PH), and liver was 
collected before and 24 h post-PH. Triacylglycerol (TG) and phosphatidylcholine (PC) species containing the 
essential linoleic acid (18:2) were analyzed (A) comparing differences in the quiescent liver species between 
both genotypes and (B) differences during the first 24 h of liver regeneration in each genotype. The results 
are represented as log2 of the fold-change. Values are mean of the fold -change from 5 animals per group and 
significant differences are denoted by *p < 0.05, **p < 0.01 and ***p < 0.001 (Student’s t test).
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significant difference were found between groups in Vldlr, Ldlr gene expression (Fig. 4B) or in CD36 and VLDLR 
protein levels (Fig. 4C).
Serum lipoproteins have been considered a source of lipids for the transient regeneration-associated steatosis in the 
liver24. Thus, we also analyzed whether these changes in lysosomal TGH activity and expression of lipoprotein recep-
tors could be linked with changes in serum TG and PC distribution into lipoproteins. Lipid distribution into serum 
lipoproteins showed that OPN deficiency did not alter TG or PC distribution into serum VLDL/ intermediate-density 
lipoprotein (IDL), LDL or high-density lipoprotein (HDL) in quiescent livers (Fig. 4D). The TG distribution into 
serum lipoproteins was also comparable in both WT and OPN-KO mice 24 h post-PH (Fig. 4E). PC distribution on 
the other hand, was altered 24 h after PH but changes were similar between OPN-KO and WT mice (Fig. 4D,E).
Atorvastatin induced changes in the lipidome 24 h after PH and promoted early liver regeneration 
in OPN-KO mice. The greatest increase in serum OPN levels occurred during the first 24 h after PH because 
no changes were observed between 24 and 48 h (Fig. 1A). This increase in serum OPN coincided with the peak 
Figure 3. Lipid oxidation is higher in OPN-KO mice than in WT mice 24 h after partial hepatectomy. 
Osteopontin knockout (OPN-KO) mice and their controls (WT) were subjected to partial hepatectomy 
(PH), and livers were collected before and 24 h and 48 h post-PH. (A) Fatty acid oxidation assay was 
performed and the released radioactive acid soluble metabolites (ASM) and CO2 were quantified. (B) Total 
acylcarnitine content was measured. (C) Representative liver sections of DHE staining and quantification. (D) 
Malondialdehyde (MDA) levels in liver samples represented in nmol/gram of tissue (left) and the content of 
oxidized fatty acids (FA) (right). Values are mean ± SEM from 4–5 animals per group. Significant differences 
between OPN-KO and the corresponding WTs are denoted by *p < 0.05 (Student’s t test); Significant differences 
along regeneration are indicated by †p < 0.05, ††p < 0.01 and †††p < 0.01 (Student’s t test).
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Figure 4. Increased liver lysosomal triacylglycerol hydrolase activity in OPN-KO mice is not linked with changes 
in circulating lipoprotein triacylglycerol and phosphatidylcholine distribution. Osteopontin knockout (OPN-KO) 
mice and their controls (WT) were subjected to partial hepatectomy (PH) and livers and serum from quiescent 
and 24 h post-hepatectomy were collected. (A) Lysosomal triacylglycerol hydrolase (TGH) activity was determined 
using a radiometric assay. (B) Hepatic mRNA levels of Cd36, very-low-density lipoprotein receptor (Vldlr) and 
low-density lipoprotein (Ldlr) genes were measured by rt-qPCR. (C) CD36 and very-low-density lipoprotein 
receptor (VLDLR) protein levels were assessed by inmmunoblotting. In all the immunoblots glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used as a loading control. Serum lipoproteins were separated into 37 
subclasses (represented as fraction numbers) (D) in quiescence and (E) 24 h post-hepatectomy. Triacylglycerol 
(TG) and phosphatidylcholine (PC) concentrations were determined in the fractionated lipoproteins: very-low/
intermediate-density lipoproteins (VLDL/IDL; fractions 1 to 11), low-density lipoproteins (LDL; fractions 12 to 
21) and high-density lipoproteins (HDL; fractions 22 to 37). Values are mean ± SEM of 4–8 animals per group. 
Statistical differences between OPN-KO and the corresponding WT mice are denoted by *p < 0.05 and **p < 0.01 
(Student’s t test) and differences along regeneration are indicated by †p < 0.05 and †††p < 0.001 (Student’s t test).
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of body weight loss (Fig. 1B). Recently, we demonstrated that in vivo inhibition of cholesterogenesis in OPN-KO 
mice livers with atorvastatin restores PC content17. In this study, we further observed that OPN modulates liver 
lipid metabolism (and liver lipidome) during regeneration after PH (Fig. 1B,C). Therefore, we evaluated if ator-
vastatin could remodel liver lipid metabolism in OPN-KO mice and analyzed the impact of atorvastatin on liver 
regeneration after PH. We found that in OPN-KO mice treatment with atorvastatin resulted in greater body 
weight loss 24 h after PH (Fig. 5A). This effect was not observed in WT mice (Fig. 5A). Atorvastatin treatment 
did not alter liver free cholesterol (FC) levels in WT or KO mice (Fig. 5B). Levels of cholesteryl ester (CE) (i.e. a 
reflection of cholesterol storage) however, were repressed with atorvastatin 24 h after PH just in OPN-KO mice 
(Fig. 5B). Atorvastatin also increased liver DG and PC content 24 h after PH in OPN-KO mice inducing no effect 
in WT mice (Fig. 5C), as we had observed in the quiescent livers17 (Fig. 5C). Atorvastatin treatment did not 
induce changes in the accumulation of lipid droplets or in the liver TG content 24 h after PH in the OPN-KO or 
WT mice (Fig. 5D). Atorvastatin treatment decreased liver DG content in OPN-KO mice 48 h after PH (Fig. 5C) 
while it did not induce changes in body weight loss or concentration in other lipids (Fig. 5A,B,D). Since we 
have observed that in OPN-KO mice the increased lipid oxidation was associated with increased DHE, here 
we wanted to know if this maintained increased after the atorvastatin treatment, that restores the lipidome. The 
results showed that differences between WT and OPN-KO in DHE disappeared after atorvastatin treatment 
(Supplemental Fig. 1).
Administration of atorvastatin to OPN-KO mice led to an increase in the liver to body weight ratio (Fig. 6A), 
in the percentage of Ki67 positive hepatocytes (Fig. 6B) and in the expression of the proliferating cell nuclear 
antigen (Pcna) (Fig. 6C) 24 h after PH as compared to non-treated OPN-KO mice. Atorvastatin did not alter 
mRNA levels of cyclin A2 (Ccna2) and cyclin D1 (Ccnd1) (Fig. 6C) and did not affect regeneration 48 h after PH 
(Fig. 6A–C, Supplemental Fig. 2). No changes in any of these parameters were observed in OPN-KO mice when 
compared with the WT mice (Fig. 6A–C). Atorvastatin treatment did not alter the liver to body weight ratio 
(Supplemental Fig. 3A) or the percentage of Ki67 positive hepatocytes (Supplemental Fig. 3B) in WT mice. In 
aggregate, these results suggest that atorvastatin induces liver regeneration in OPN-KO mice only 24 h post-PH, 
when it induces a new lipidome profile.
Discussion
OPN is a multifunctional cytokine involved in different liver disorders related with activation of a regenerative 
response, such as obesity related steatosis25, non-alcoholic steatohepatitis15, fibrosis15, or hepatocellular carci-
noma26. Different studies have also shown that OPN is involved in liver regeneration after PH16,18. Wen et al.18 
demonstrated that in mice OPN is required for hepatocyte proliferation during the priming phase; Wang et al.16 
showed that in rats OPN overexpression aggravated hepatic necrosis and leukocyte infiltration while OPN silenc-
ing inhibited liver regeneration rate in later stages than in mice.
Liver regeneration is an important topic of study due to its implication in liver diseases and its importance 
in auxiliary (split) liver transplantations27,28. For a successful initiation and completion of liver regeneration 
the remaining cells within the liver need to acquire sufficient energy and precursors to support the metabolic 
demands of rapid proliferation, which involve an immense metabolic remodeling1. We previously showed that 
OPN regulates de novo lipogenesis in hepatocytes and glycerolipid metabolism17. So, there is a need to understand 
how OPN affects lipid metabolism during regeneration. In this study, we show that there is a substantial increase 
in the levels of circulating OPN during the first 24 h after PH, occurring at a time when hepatocytes accumulate a 
significant amount of lipids (mainly TGs), in droplets, in the widely recognized transient regeneration-associated 
liver steatosis9,29. Evidences suggest that the transient steatosis is likely related to the increase lipogenic activity 
and the altered lipid fluxes into and out of the hepatocyte9,21,30.
Previously, we also demonstrated that de novo TG synthesis is decreased while the liver TG content maintains 
unaltered in OPN-KO hepatocytes17. Here, we further show that enrichment of liver TGs in the most abundant 
dietary essential FA, the linoleic acid (18:2), occurs in OPN-KO mice. This enrichment is associated with an 
increase in the lysosomal TGH activity, involved in the internalized lipoprotein lipid hydrolysis. All together, 
these results show that the decreased de novo TG synthesis is compensated with dietary FA in OPN-KO mice 
livers. During the first 24 h period after PH, the enrichment of TGs in linoleic acid was higher in the WT than in 
OPN-KO mice, in which beta oxidation was increased. All together, suggesting an increased catabolism of dietary 
fatty acids.
Disruptions in hepatic adipogenesis have been associated with impaired liver regeneration in mice31. Our 
findings demonstrated that in OPN-KO female mice liver, in which the source of TGs is different, regeneration 
was not impaired 24 or 48 h after PH. It has also been described that during the first hours of the G1 phase there 
is an increase in the TG hydrolysis that releases FAs for mitochondrial beta oxidation32. Here we observed that in 
OPN-KO mice there is an increase in beta oxidation 24 h after PH, which prevents the accumulation of acylcar-
nitines observed in quiescent livers and will induce the decrease in acylcarnitines 48 h after PH. This increase in 
beta oxidation is coupled with the increase in positive cells for DHE, a marker of ROS. It has been described that 
the hypoglycaemia that follows PH induces systemic lipolysis which supplies the required FA8. The loss of body 
weight that follows the PH is less marked in OPN-KO mice than in WT mice, suggesting that lipolysis of adipose 
tissue is not the source of FA for the increased beta oxidation. These results are in concordance with the fact that 
in mice, OPN deletion, prevents the development of obesity and hepatosteatosis via impaired adipose tissue func-
tionality25. Our results suggest that dietary FA will provide the required TG and FA for lipid accumulation and 
beta oxidation in OPN-KO mice.
The synthesis of PC, the major phospholipid in cellular membranes, is coordinated with the cell cycle activa-
tion2. However, lack of CTP:phosphocholine cytidyltransferase in mice, the rate limiting enzyme responsible for 
70% of liver PC5, does not attenuate liver regeneration after PH6. Our results show that liver regeneration is not 
impaired in OPN-KO mice even when PC content is decreased 24 h post PH. We also found that the decreased 
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Figure 5. In OPN-KO mice atorvastatin treatment induces changes in liver lipidome 24 h after partial 
hepatectomy. Osteopontin knockout (OPN-KO) mice, OPN-KO mice treated with atorvastatin (100 mg/kg), 
and their respective controls treated or untreated with atorvastatin (WT) were subjected to partial hepatectomy 
(PH) and livers were collected before and 24 h and 48 h post-hepatectomy. (A) Percentage of body weight loss. 
(B) Liver free cholesterol (FC), cholesteryl ester (CE). (C) diacylglycerol (DG) and phosphatidylcholine (PC) 
content are represented in nmol/gram of liver. (D) Representative liver sections stained with Sudan III (left) and 
liver triacylglycerol (TG) content (right) is represented in nmol/gram of liver. Values are mean ± SEM of 4–8 
animals per group. Statistical differences between treated or untreated mice within one genotype are denoted by 
*p < 0.05 (Student’s t test) and differences along regeneration and between genotype are indicated by †p < 0.05, 
††p < 0.01 and †††p < 0.001 (Student’s t test).
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de novo PC synthesis previously observed is associated reduced liver PC content, but unlike TGs, PC content is 
not compensated with the dietary essential FA linoleic. Importantly, treatment with atorvastatin, which inhibits 
cholesterogenesis, induces a new lipidome landscape where PC and DG content increases 24 h after PH. This 
new metabolic rewiring was associated with improved liver regeneration 24 h after PH, and is consistent with our 
previous reports of increased de novo cholesterogenesis in OPN-KO mice.
This study reinforces the role of OPN as a metabolic driver during liver regeneration. However, in this mice 
model, non-obese with healthy liver, the lack of OPN results in a metabolic remodeling ensuring the success in 
regeneration 24 and 48 h after partial hepatectomy. OPN is increased in liver diseases and the knockdown of OPN 
has been proposed as a therapeutical approach. However, through this study we are not able to know if the lack of 
OPN will alter liver regeneration in a model of obesity with non-alcoholic fatty liver disease. Liver transplants are 
increasing due to metabolic disease. Thus, this should be investigated in the future.
In conclusion, the results here support the role of OPN as a liver metabolic driver. OPN regulates multiple 
metabolic pathways involved in liver regeneration. Treatment with atorvastatin, an inhibitor of de novo choles-
terogenesis, provides a new metabolic scenario linked to improvement of early regeneration in OPN-KO mice.
Methods
Animals. 10–12-week-old female OPN-KO mice and their WT littermates were provided by Jackson´s 
Laboratories. They were maintained on a rodent chow diet (Teklad Global 18% Protein Rodent Diet 2018S; Harlan 
Laboratories INC., USA) and were housed in a temperature-controlled room with a 12 hour-light/ dark cycle. 
Animal procedures were approved by the Ethics Committee for Animal Welfare of the University of the Basque 
Country UPV/EHU and were conducted in conformity with the EU Directives for animal experimentation.
Partial hepatectomy. Mice were subjected to 70% PH, as previously described33 under general anesthesia 
with inhaled isoflurane. Animals were sacrificed at different times (24 h, 48 h and 72 h) after surgery.
Figure 6. Atorvastatin improves regeneration 24 h after partial hepatectomy in OPN-KO mice. Wild type 
(WT), osteopontin knockout (OPN-KO) and OPN-KO treated with atorvastatin (100 mg/kg) mice were 
subjected to partial hepatectomy (PH) and livers from quiescent, 24 h and 48 h post-hepatectomy were collected. 
(A) The percentage of body/liver weight was calculated. (B) Ki67 immunostaining was performed. (C) Hepatic 
mRNA levels of genes implicated in cell cycle progression were measured. Values are mean ± SEM from 5–10 
animals per group. Significant differences between OPN-KO and WT mice are denoted by *p < 0.05 (Student’s 
t test). Differences between OPN-KO and OPN-KO treated with atorvastatin are indicated by #p < 0.05 and 
##p < 0.01. Differences along regenration are indicated by †p < 0.05, ††p < 0.01 and †††p < 0.001 (Student’s t test).
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Atorvastatin treatment. Intragastric atorvastatin (100 mg/kg) was provided to a group of OPN deficient 
animals during 2 weeks in alternate days. 24 h hours after the last dose the mice were subjected to 70% PH and 
were sacrificed at different times (24 h and 48 h) after surgery.
Liver lipidomic analysis. Liver lipid profiles were analyzed in OWL as described previously34. Briefly, two 
separate UPLC-time-of- flight (TOF)-mass spectrometry (MS)-based platforms analyzing methanol and chloro-
form/methanol liver extracts were combined. Identified ion features in the methanol extract platform included 
acylcarnitines, monoacylglycerophospholipids (LPC) and oxidized FAs. The chloroform/methanol extract plat-
form provided coverage over glycerolipids. Lipid nomenclature follows the LIPID MAPS convention (www. lipid-
maps.org)
FA oxidation. Beta oxidation was assessed as described before35,36. Fresh liver pieces were homogenated in a 
Potter homogenizer (5 strokes) in cold buffer (25 mM Tris-HCl, 500 nM sucrose, 1 mM EDTA-Na2 pH 7,4) and 
sonicated for 10 s. Then, the homogenates were centrifuged at 500 × g for 10 min at 4 °C. Approximately 500 µg of 
protein from the homogenates supernatant was used for the assay in a volume of 200 µl. The reaction started by 
adding 400 µl of assay mixture containing 0.5 µCi/ml [1-14C] palmitic acid to the samples and was incubated for 
1 h at 37 °C in eppendorf tubes with a Whatman paper circle in the cap. The reaction was stopped by adding 300 µl 
of 3 M perchloric acid and 1 M NaOH was added to impregnate the whatman cap.
After 2 h the Whatman caps were retired and the radioactivity associated was measured in a scillation counter. 
The eppendorf tubes were centrifugated at 21,000 × g 10 min at 4 °C. 400 µl from the supernatant were collected 
and the radioactivity was counted in a scintillation counter. The supernatant contained the acid soluble metabo-
lites (ASM) and the Whatman caps captured the released CO2.
Analysis of liver lipid concentration. After homogenization of liver tissue, lipids were extracted as 
described before37. PC, FC, CE and DG were quantified as described previously38 and TGs were quantified using 
a commercially available kit (A. Menarini Diagnostics, Italy).
TG and PC distribution in serum lipoprotein subclasses. Serum lipoproteins were separated using 
an AKTA-fast-protein liquid chromatography using a Superose 6 10/300 GL column (GE Healthcare Europe 
GmbH, Germany) as detailed39. After equilibration, 200 µl of serum were applied and fractions were collected. 
Commercially available kits were used to measure TG (A. Menarini Diagnostics, Spain) and PC (Spinreact, Spain) 
in each fraction.
Lipid peroxidation Assay kit. Malondialdehyde (MDA) content is generally used as marker for lipid per-
oxidation. MDA content in liver samples was quantified by using a commercially available kit from Sigma-Aldrich 
(St. QuentilFallavier, France).
Determination of ROS in liver tissue sections. Samples were sectioned in a criostat (8 μms), and incu-
bated with MnTBAP 150 μM at RT during 1 h. The samples were then incubated with DHE 5 μM for 30 min at 
37 °C40. Sections were mounted with mounting media containing DAPI.
Osteopontin ELISA. During regeneration, OPN was quantified in the serum of WT mice using OPN 
Quantikine ELISA kit (R&D Systems) according to the manufacturer’s protocol.
Histology. A piece of liver was formalin-fixed and 4 microm-thick sections were stained with hematoxylin 
and eosin (Neiker-Tecnalia, Spain) following standard methods.
For the histological evaluation of lipid storage in liver, Sudan Red staining was performed. Briefly, cut liver 
cryostat section of 8 microms were incubated with freshly-prepared Sudan III stain (Sigma-Aldrich) and con-
trasted with Mayers hematoxylin. Stained area percentage of each sample were calculated using FRIDA software 
(FRamework for Image Dataset Analysis) http://bui3.win.ad.jhu.edu/frida/.
Inmunoassays. To quantify the regeneration rate, Ki67 immunostaining of formaline fixed liver sections 
was performed24 by incubation with anti-Ki67 primary antibody (1:1500) (Novocastra Reagents, UK) at 4 °C 
overnight.
For the immunoblots, samples were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophore-
sis (SDS-PAGE) and proteins were transferred to Immobilon-P membranes. Western blotting was performed 
using different primary antibodies: Phosphorylated (Thr-147) phospholipase D1 (P-PLD1) and total PLD1 from 
Cell Signaling Technology, calcium free posphorylated (Ser-505) phospholipase A2 (P-PLA2), total PLA2 and 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from Abcam, CD36 from NOVUS and VLDLR from 
R&D Systems.
Analysis of lysosomal TGH activity. Lysosomes enriched fractions were isolated from liver homogenates 
by differential centrifugation essentially as described before41. TGH enzymatic activities were measured using 
radiometric assays as previously described42,43.
RNA extraction, cDNA synthesis and qPCR. Total RNA was extracted using Trizol Reagent (Invitrogen, 
Spain) and cDNAs were obtained by retrotranscription (SuperScript III RT, Invitrogen, USA) following the man-
ufacturers’ instructions.
cDNA was used for specific target amplification using the Qiagen Multiplex PCR Master, after 14 cycles of 
amplification (95 °C 15 min, 14 cycles 95 °C for 15 sec and 60 °C for 4 min), amplified cDNA was treated with Exo 
I following Fluidigm protocol instructions, diluted 1:5 with low EDTA TE buffer and loaded onto 48.48 or 96.96 
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Dynamic Array IFC. SsoFastTM EvaGreen® Supermix with Low ROX (Bio-Rad Laboratories, USA) is used for 
amplification. The cycling program consisted of 1 min at 95 °C, 35 cycles of 95 °C for 5 sec and 60 °C for 20 secs, 
followed by a melting curve.
The expression of the selected genes was measured by RT-qPCR using the BioMarkTM HD system in combi-
nation with Dynamic Array Integrated Fluidic Circuits (IFC) (Fluidigm Corporation, USA) following Fluidigm’s 
Fast Gene Expression Analysis using EvaGreen on the BioMark HD System version D1 protocol. Finally, the 
stability of candidate reference genes was analyzed with NormFinder algorithms and all the data analysis was per-
formed using GenEx software. The oligonucleotides and sequences used for quantitative PCR analysis were the 
following ones: Cd36 (Fw: CCCTCCAGAATCCAGACAAC; Rv: CACAGGCTTTCCTTCTTTGC), Vldlr (Fw: TG 
ACGCAGACTGTTCAGACC; Rv: GCCGTGGATACAGCTACCAT) and Ldlr (Fw: AGGCTGTGGGCTC 
CATAGG; Rv: TGCGGTCCAGGGTCATCT). All reactions were performed in duplicate, and expression levels were 
normalized to the average level of Gapdh (Fw: TATGACTCCACTCACGGCAAATT; Rv: TCGCTCCTGGAAGA 
TGGTGAT), Ppia (Fw: CCAAGACTGAGTGGCTGGATG; Rv: GCTCCATGGCTTCCACAATG), and Actb 
(Fw: ATCGCTGACAGGATGCAGAAG; Rv: TCAGGAGGAGCAATGATCTTGA) in each sample.
Total protein measurements. Protein concentration was measured using commercially available 
Bicinchoninic Acid Reagent (Thermo Fisher Scientific Inc).
Statistical analysis. Data are represented as mean ± SEM. Differences between groups were tested using 
the Student’s t test. Significance was defined as p < 0.05. These analyses were performed using GraphPad Prism 
software.
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author on reasonable request.
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